Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Genotype-guided approach to improve cardiometabolic health using natriuretic peptides

Official title: Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study

Run by University of Alabama at Birmingham · NCT05216042 · Data updated 2026-11-12

This study is testing if a special approach using natriuretic peptides can help improve heart and metabolic health in adults with a certain genetic variant that leads to lower levels of these peptides.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations1 site (Birmingham, Alabama)
StatusRecruiting
StartedApril 1, 2022
Main results expectedApril 1, 2027
Study endsApril 30, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT05216042 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who consent to genetic material collection and are willing to adhere to the study protocol.

Probably not a fit

Patients with a history of cardiovascular diseases, diabetes, or those with severe obesity (BMI > 45 kg/m2) may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the role of natriuretic peptides (NPs) in regulating cardiometabolic health, particularly in individuals with genetically lower NP levels. It focuses on understanding how exercise and glucose challenges affect NP responses in adults who carry a specific genetic variant associated with lower NP levels. The study aims to explore the metabolic benefits of NPs and their potential to mitigate risks associated with cardiovascular diseases and diabetes. Participants will undergo dietary assessments, exercise capacity evaluations, and challenges to assess their metabolic responses.

Why it matters

Potential benefit: If successful, this study could lead to improved strategies for managing cardiometabolic health in individuals with low natriuretic peptide levels.

How similar studies have gone: Previous studies have indicated the importance of natriuretic peptides in metabolic health, suggesting that this approach may yield beneficial insights, although the specific genetic focus is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults: Age more than or equal to 18; an equal number of Males and Females
* Consent to the collection of genetic material
* Willing to adhere to the study protocol

Exclusion Criteria:

* Age \<18, at screening.
* BMI \>45 kg/m2.
* Blood pressure more than 140/90 mmHg.
* Participants who are taking more than 2 hypertension medications.
* History of diabetes or fasting plasma glucose \>126 mg/dl or HbA1C\>=6.5% or prior treatment with antidiabetic medication.
* Have any past or present history of cardiovascular diseases (stroke, seizure, myocardial infarction, heart failure, transient ischemic attack, angina, or cardiac arrhythmia)
* Women who are pregnant or breastfeeding or who can become pregnant and not practicing an acceptable method of birth control during the study (including abstinence);
* Estimated GFR \< 60 ml/min/1.73 m2; albumin creatinine ratio ≥30 mg/g
* Hepatic Transaminase (AST and ALT) levels \>3x the upper limit of normal
* Anemia (men, Hct \< 38%; women, Hct \<36%)
* Inability to exercise on a treadmill

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting

Study contacts

  • Principal investigator: Pankaj Arora, MD, FAHA — University of Alabama at Birmingham
  • Study coordinator: Nehal Vekariya, MS
  • Email: nvekariya@uabmc.edu
  • Phone: 205-934-7173

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.